Every one of those 1 sits in a single category, medical-devices. Of the tracked stories, 1 of 1 also mention CooperCompanies, the most common co-covered peer. Each story carries 2 original sources on average, compared with 2.8 for the broader beat in this window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about CooperSurgical
Every one of those 1 sits in a single category, medical-devices. Of the tracked stories, 1 of 1 also mention CooperCompanies, the most common co-covered peer. Each story carries 2 original sources on average, compared with 2.8 for the broader beat in this window. The 5 average consequence score is below the beat benchmark of 5.8 in the same window. We currently track 1 Healthcare story that mention CooperSurgical, all published on March 5, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 25 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering CooperSurgical. Shared-story counts are live from our verified record — not editorial picks.
CooperCompanies (NASDAQ: COO) reported fourth-quarter 2025 financial results that met analyst expectations, driven by consistent performance across its CooperVision and CooperSurgical business units. The results underscore the company's resilience in the medical device sector despite broader macroeconomic fluctuations.